Hui Yang
Zhejiang Chinese Medical University(CN)Pennsylvania State University(US)Allen Institute for Brain Science(US)Army Medical University(CN)Hangzhou Normal University(CN)Fudan University(CN)Nanjing General Hospital of Nanjing Military Command(CN)North Minzu University(CN)Xinqiao Hospital(CN)National Clinical Research(US)Hangzhou First People's Hospital(CN)Huashan Hospital(CN)Nanjing University(CN)
Publications by Year
Research Areas
Immune cells in cancer, Glioma Diagnosis and Treatment, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Immune Cell Function and Interaction
Most-Cited Works
- → Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases(2011)2,802 cited
- → Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors(2012)1,097 cited
- → Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation(2012)578 cited
- → IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives(2012)425 cited
- → WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation(2015)303 cited
- → Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic(2020)285 cited